cysteine has been researched along with Cancer of Prostate in 60 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (3.33) | 18.7374 |
| 1990's | 6 (10.00) | 18.2507 |
| 2000's | 17 (28.33) | 29.6817 |
| 2010's | 27 (45.00) | 24.3611 |
| 2020's | 8 (13.33) | 2.80 |
| Authors | Studies |
|---|---|
| Ball, RY; Bernuzzi, F; Livingstone, TL; Mills, RD; Mithen, RF; Saha, S; Savva, GM; Traka, MH; Troncoso-Rey, P | 1 |
| Asemota, S; Bocharova, V; He, Y; Hwang, DJ; Jain, AK; Johnson, DL; Miller, DD; Narayanan, R; Petricoin, EF; Pfeffer, LM; Ponnusamy, S; Thiyagarajan, T; Yin, Z; Young, KL; Zhou, W | 1 |
| Clark, R; DiGiovanni, J; Friedman, CA; Georgiou, G; Kidane, D; Kindall, A; Saha, A; Stone, E; Wilder, C; Zhao, S | 1 |
| Bossis, I; Rowley, T; Viscidi, RP | 1 |
| Filippov, DV; Lehtiö, L; Overkleeft, HS; Paschal, BM; Vela-Rodríguez, C; Wijngaarden, S; Yang, C | 1 |
| Chen, H; Chen, J; Chen, X; Gu, Y; Huang, S; Wang, H; Wu, X; Xu, Y; Zhang, H; Zhang, Y | 1 |
| Ma, S; Ruzzo, WL; Wang, Y | 1 |
| Al-Salemee, F; Bartnicka, JJ; Blower, PJ; Firth, G | 1 |
| Adler, S; Afari, G; Bednarova, S; Berman, R; Bhattacharyya, S; Choyke, PL; Eclarinal, P; Hill, C; Jacobs, PM; Lindenberg, L; McKinney, Y; Mease, RC; Mena, E; Merino, MJ; Pinto, PA; Pomper, MG; Ton, AT; Turkbey, B; Wood, BJ | 1 |
| Abarghoei, S; Borghei, YS; Fakhri, N; Ganjali, MR; Hosseini, M | 1 |
| Collins, J; Murphy, JM; Tavaré, R; Tsai, WK; Waldmann, CM; Wu, AM; Zettlitz, KA | 1 |
| Bagalà, P; Barbarino, R; Cicchetti, S; Di Cristino, D; Di Murro, L; Falco, MD; Janniello, D; Morelli, P; Murgia, A; Ponti, E; Santoni, R; Terenzi, S; Tolu, B; Tortorelli, G | 1 |
| Chaiswing, L; Oberley, TD; Zhong, W | 1 |
| Borges, CR; Breburda, C; Jensen, S; Nikolova, B; Rehder, DS; Schaab, MR; Sherma, ND; Yassine, H | 1 |
| Blessing, AM; Bollu, LR; Gao, G; Katreddy, RR; Ren, J; Su, F; Wang, J; Weihua, Z; Xu, L | 1 |
| Anuszewska, E; Flis, A; Hoser, G; Jastrzębski, Z; Królikowska, MA; Książek, I; Remiszewska, M; Sitarz, K; Śliwka, L; Sochacka, M; Suchocka, Z; Suchocki, P; Wroczyński, P | 1 |
| Boerman, OC; Bolkestein, M; Chatalic, KL; de Jong, M; Hoeben, S; Koning, GA; van Weerden, WM; Veldhoven-Zweistra, J | 1 |
| Bivalacqua, TJ; Blackford, A; Carter, HB; Cho, SY; Cornish, TC; Dannals, RF; Faraj, SF; Gage, KL; Gonzalez-Roibon, N; Guner, G; Han, M; Holt, D; Lodge, MA; Macura, KJ; Mease, RC; Munari, E; Netto, GJ; Partin, AW; Pavlovich, CP; Pomper, MG; Rowe, SP | 1 |
| Bianchini, F; Calvani, M; Chiarugi, P; Comito, G; Giannoni, E; Morandi, A; Raugei, G; Richichi, B; Taddei, ML; Tang, D; Wong, N | 1 |
| Geng, Y; Hu, Y; Lin, K; Tian, H; Wu, S; Wu, W; Yang, G; Zhou, Y | 1 |
| Alters, SE; Cramer, SL; DiGiovanni, J; Georgiou, G; Huang, P; Keating, MJ; Lamb, C; Liu, J; Rowlinson, S; Saha, A; Stone, E; Tadi, S; Tiziani, S; Triplett, K; Yan, W; Zhang, YJ | 1 |
| Drzezga, A; Gorin, MA; Pomper, MG; Rowe, SP; Salas Fragomeni, RA | 1 |
| DE LA CAUDRA, JL; WILBRANDT, W | 1 |
| He, M; Kawamura, T; Vanaja, DK; Yin, P; Young, CY | 1 |
| Bonorden, MJ; Cleary, MP; Hu, H; Lee, HJ; Li, GX; Liao, JD; Lü, J; Wang, L; Zhang, Y | 1 |
| Bergh, A; Hallmans, G; Hultdin, J; Johansson, M; Key, T; Midttun, O; Stattin, P; Ueland, PM; Van Guelpen, B; Vollset, SE | 1 |
| Inoue, T; Kamba, T; Kamoto, T; Maeno, A; Nakamura, E; Ogawa, O; Shimizu, Y; Terada, N; Yoshida, T | 1 |
| Canene-Adams, K; Diamond, AM; Erdman, JW; Ford, NA; Lindshield, BL; Wallig, MA | 1 |
| Barnetson, R; Doyle, B; Fleming, J; Kozielski, F; Leung, HY; Robson, CN; Singh, BL; Stockley, J; Wiltshire, C | 1 |
| Anderson, LB; Lü, J; Wang, L; Witthuhn, B; Xu, Y; Zhang, J | 1 |
| Dong, Y; Gao, L; Gao, R; Liu, X; Zhang, H; Zhao, L; Zhao, X; Zhao, Y | 1 |
| Ding, ST; Fujii, N; Inoue, T; Kobayashi, T; Lv, JJ; Nishiyama, H; Nishizawa, K; Ogawa, O; Oishi, S; Saito, R; Xing, ND | 1 |
| Grimes, SR | 1 |
| Cleary, MP; Liao, JD; Lü, J; Nkhata, K; Quealy, E; Wang, L; Zhang, J; Zhang, Y | 1 |
| Huang, HC; Koria, P; Nanda, A; Rege, K; Yang, Y | 1 |
| Anderson, LB; Li, G; Lü, J; Wang, L; Witthuhn, B; Xu, Y; Zhang, J | 1 |
| Chen, K; Chen, R; Li, M; Liu, J; Liu, Z; Wang, T; Yang, J; Yang, W; Ye, Z | 1 |
| Chaiswing, L; Jones, DP; Liang, Y; Oberley, TD; Zhong, W | 1 |
| Carducci, MA; Cho, SY; Dannals, RF; Eisenberger, MA; Endres, CJ; Gage, KL; Holt, DP; Jeffrey-Kwanisai, A; Kozikowski, AP; Lodge, M; Mease, RC; Pomper, MG; Rodriguez, R; Rojas, C; Senthamizhchelvan, S; Sgouros, G; Slusher, BS | 1 |
| Altieri, DC; Chheang, S; Fornaro, M; King, M; Languino, LR; Plescia, J; Tallini, G; Zhu, YM | 1 |
| Cross, JV; Templeton, DJ | 1 |
| Danishefsky, SJ; Keding, SJ | 1 |
| Chen, C; Cheng, X; Dong, JT; Dong, XY; Guo, P; Ling, J; Lingrel, JB; Sethi, P; Simons, JW; Sun, X; Zhou, J | 1 |
| Abdul, M; Hoosein, N | 1 |
| Dong, Y; Gao, AC; Ip, C; Lee, SO; Nadiminty, N; Trump, DL; Yeon Chun, J | 1 |
| Azrak, RG; Foster, BA; Frank, CL; Li, F; Ling, X; Rustum, YM; Slocum, HK | 1 |
| Chu, Q; Lee, DT; Tsao, SW; Wang, X; Wong, YC | 1 |
| Cheung, HW; Chua, CW; Howard, EW; Ling, MT; Wang, X; Wong, YC | 1 |
| Chiu, YT; Chua, CW; Howard, EW; Lee, DT; Wang, X; Wong, YC | 1 |
| Duatti, A; Faintuch, BL; Faintuch, S; Muramoto, E; Smith, CJ; Teodoro, R | 1 |
| Dannals, RF; Dusich, CL; Foss, CA; Fox, JJ; Kozikowski, AP; Mease, RC; Pomper, MG; Prideaux, A; Ravert, HT; Seidel, J; Sgouros, G | 1 |
| Alitalo, K; Chilov, D; Joukov, V; Kaipainen, A; Kalkkinen, N; Kukk, E; Lahtinen, I; Pajusola, K; Saksela, O | 1 |
| Anagnostou, A; Hooker, J; Sigounas, G; Steiner, M | 1 |
| Heston, WD; Pinto, JT; Protomastro, ML; Qiao, C; Rivlin, RS; Tao, Y; Thaler, H; Weissler, ML; Xing, J | 1 |
| Aoyagi, K; Garcia, FU; Hu, Y; Shima, I; Stearns, ME; Wang, M | 1 |
| Gabarra, V; Gallagher, BC; Hanigan, MH; Townsend, DM | 1 |
| Bingman, WE; Edwards, DP; James, AJ; Lamb, DJ; Mancini, M; Marcelli, M; Nazareth, LV; Stenoien, DL; Weigel, NL; Wu, C; Zhang, Y | 1 |
| Bacich, DJ; Heston, WD; Huryk, RF; Pinto, JT; Qiao, C; Rivlin, RS; Schubert, KB; Suffoletto, BP; Xing, J | 1 |
| Nathan, C; Shen, C | 1 |
| Abramson, M; Huang, CC; Wu, CH | 1 |
2 review(s) available for cysteine and Cancer of Prostate
| Article | Year |
|---|---|
Bioengineered Bovine Papillomavirus L1 Protein Virus-like Particle (VLP) Vaccines for Enhanced Induction of CD8 T Cell Responses through Cross-Priming.
Topics: Animals; Antibodies, Viral; Cancer Vaccines; Capsid Proteins; CD8-Positive T-Lymphocytes; Cross-Priming; Cysteine; Humans; Male; Mice; Prostatic Neoplasms; Vaccines, Virus-Like Particle | 2023 |
Clinical Experience with
Topics: Antigens, Surface; Cysteine; Drug Evaluation, Preclinical; Fluorine Radioisotopes; Glutamate Carboxypeptidase II; Glutarates; Humans; Lysine; Male; Organophosphonates; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Urea | 2017 |
3 trial(s) available for cysteine and Cancer of Prostate
| Article | Year |
|---|---|
Accumulation of Sulforaphane and Alliin in Human Prostate Tissue.
Topics: Allium; Antioxidants; Brassica; Cysteine; Glucosinolates; Humans; Imidoesters; Isothiocyanates; Male; Prostate; Prostatic Neoplasms; Sulfoxides | 2022 |
18F-DCFBC Prostate-Specific Membrane Antigen-Targeted PET/CT Imaging in Localized Prostate Cancer: Correlation With Multiparametric MRI and Histopathology.
Topics: Aged; Antigens, Surface; Cysteine; Glutamate Carboxypeptidase II; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prospective Studies; Prostatectomy; Prostatic Neoplasms | 2017 |
Biodistribution, tumor detection, and radiation dosimetry of 18F-DCFBC, a low-molecular-weight inhibitor of prostate-specific membrane antigen, in patients with metastatic prostate cancer.
Topics: Aged; Aged, 80 and over; Antigens, Surface; Biological Transport; Cysteine; Glutamate Carboxypeptidase II; Humans; Male; Middle Aged; Molecular Weight; Neoplasm Metastasis; Positron-Emission Tomography; Prostatic Neoplasms; Protease Inhibitors; Radiometry; Tissue Distribution | 2012 |
55 other study(ies) available for cysteine and Cancer of Prostate
| Article | Year |
|---|---|
Inhibiting androgen receptor splice variants with cysteine-selective irreversible covalent inhibitors to treat prostate cancer.
Topics: Androgen Receptor Antagonists; Cell Line, Tumor; Cysteine; Humans; Male; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Protein Isoforms; Receptors, Androgen | 2023 |
Cysteine depletion sensitizes prostate cancer cells to agents that enhance DNA damage and to immune checkpoint inhibition.
Topics: Androgens; Cell Line, Tumor; Cysteine; Cystine; Cysts; DNA; DNA Damage; Humans; Immune Checkpoint Inhibitors; Male; Prostatic Neoplasms; Reactive Oxygen Species | 2023 |
Synthetic Dual Cysteine-ADP Ribosylated Peptides from the Androgen Receptor are Recognized by the DTX3L/PARP9 Complex.
Topics: Adenosine Diphosphate Ribose; ADP-Ribosylation; Cysteine; Humans; Male; Neoplasm Proteins; Peptides; Poly(ADP-ribose) Polymerases; Prostatic Neoplasms; Receptors, Androgen; Ubiquitin-Protein Ligases | 2023 |
Study on the cellular internalization mechanisms and
Topics: Animals; Arginine; Aspartic Acid; Bone Neoplasms; Cell Line, Tumor; Cell Movement; Cell Survival; Cysteine; Genetic Vectors; Male; Membrane Proteins; Mice; Mice, Inbred BALB C; Nanoparticles; Particle Size; Peptide Fragments; Peptide T; Polyethylene Glycols; Prostatic Neoplasms; Tumor Burden | 2020 |
Spatial modeling of prostate cancer metabolic gene expression reveals extensive heterogeneity and selective vulnerabilities.
Topics: Arachidonic Acid; Cysteine; Databases, Factual; Humans; Male; Metabolic Networks and Pathways; Organic Anion Transporters; Prostatic Neoplasms; Stearoyl-CoA Desaturase; Succinic Acid; Suramin; Tumor Microenvironment | 2020 |
L-Cysteine-mediated modulation of copper trafficking in prostate cancer cells: an
Topics: Biological Transport; Cell Line, Tumor; Copper; Copper Radioisotopes; Cysteine; Humans; Male; PC-3 Cells; Positron-Emission Tomography; Prostatic Neoplasms | 2020 |
A colorimetric paper sensor for citrate as biomarker for early stage detection of prostate cancer based on peroxidase-like activity of cysteine-capped gold nanoclusters.
Topics: Biomarkers, Tumor; Citric Acid; Colorimetry; Cysteine; Gold; Humans; Lab-On-A-Chip Devices; Limit of Detection; Male; Microscopy, Electron, Transmission; Nanostructures; Paper; Peroxidase; Prostatic Neoplasms; Spectrometry, Fluorescence | 2019 |
A Dual-Modality Linker Enables Site-Specific Conjugation of Antibody Fragments for
Topics: Animals; Antibodies; Antigens, Neoplasm; Carbocyanines; Cyclooctanes; Cysteine; Fluorescence; Fluorescent Dyes; Fluorine Radioisotopes; GPI-Linked Proteins; Humans; Immunoglobulin Fragments; Male; Mice; Microscopy, Fluorescence; Neoplasm Proteins; Neoplasm Transplantation; Optical Imaging; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Tissue Distribution | 2019 |
Fatigue in patients undergoing radiation therapy: an observational study.
Topics: Albumins; Breast Neoplasms; Cysteine; Dietary Supplements; Fatigue; Female; Humans; Lactoferrin; Male; Milk Proteins; Prostatic Neoplasms; Quality of Life; Surveys and Questionnaires; Whey Proteins | 2013 |
Increasing discordant antioxidant protein levels and enzymatic activities contribute to increasing redox imbalance observed during human prostate cancer progression.
Topics: Adenocarcinoma; Cell Line, Tumor; Cysteine; Disease Progression; Humans; Male; Neoplasm Grading; Oxidation-Reduction; Oxidative Stress; Peroxiredoxins; Prostate; Prostatic Neoplasms; Protein Processing, Post-Translational; Superoxide Dismutase; Thioredoxins | 2014 |
Elevated plasma albumin and apolipoprotein A-I oxidation under suboptimal specimen storage conditions.
Topics: Apolipoprotein A-I; Chromatography, Liquid; Cryopreservation; Cysteine; Diabetes Mellitus, Type 2; Freezing; Humans; Male; Methionine; Myocardial Infarction; Oxidation-Reduction; Oxidative Stress; Prostatic Neoplasms; Serum Albumin; Specimen Handling; Spectrometry, Mass, Electrospray Ionization | 2014 |
Involvement of de novo synthesized palmitate and mitochondrial EGFR in EGF induced mitochondrial fusion of cancer cells.
Topics: Breast Neoplasms; Cell Line, Tumor; Cysteine; Drug Resistance; Epidermal Growth Factor; ErbB Receptors; Fatty Acid Synthase, Type I; Female; Humans; Male; Mitochondria; Mitochondrial Dynamics; Mitochondrial Proteins; Palmitates; Prohibitins; Prostatic Neoplasms; Protein Array Analysis; Protein Kinase Inhibitors; Protein-Tyrosine Kinases | 2014 |
Selenitetriglycerides-Redox-active agents.
Topics: Aged; Animals; Antineoplastic Agents; Cysteine; Cystine; Extracellular Space; Humans; Liver; Male; Mice; Mice, Inbred NOD; Mice, SCID; Oxidation-Reduction; Oxidative Stress; Prostatic Neoplasms; Selenium; Selenium Compounds; Sulfhydryl Compounds; Tissue Distribution; Triglycerides | 2015 |
A Novel ¹¹¹In-Labeled Anti-Prostate-Specific Membrane Antigen Nanobody for Targeted SPECT/CT Imaging of Prostate Cancer.
Topics: Animals; Antigens, Surface; Autoradiography; Cell Line, Tumor; Cysteine; Flow Cytometry; Glutamate Carboxypeptidase II; Histidine; Humans; Kidney; Male; Mice; Multimodal Imaging; Nanomedicine; Neoplasm Transplantation; Oligopeptides; Peptide Library; Prostatic Neoplasms; Protein Structure, Tertiary; Proto-Oncogene Proteins c-myc; Single-Domain Antibodies; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed | 2015 |
¹⁸F-DCFBC PET/CT for PSMA-Based Detection and Characterization of Primary Prostate Cancer.
Topics: Aged; Antigens, Surface; Biomarkers, Tumor; Biopsy; Cysteine; Fluorodeoxyglucose F18; Glutamate Carboxypeptidase II; Humans; Hypertrophy; Immunohistochemistry; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Metastasis; Positron-Emission Tomography; Prostatectomy; Prostatic Neoplasms; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Targeting stromal-induced pyruvate kinase M2 nuclear translocation impairs oxphos and prostate cancer metastatic spread.
Topics: Active Transport, Cell Nucleus; Animals; Binding Sites; Carcinoma; Carrier Proteins; Cell Line, Tumor; Cell Nucleus; Cohort Studies; Cysteine; Fibroblasts; Glucose; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Lactic Acid; Male; Membrane Proteins; Metformin; Mice; Mice, SCID; MicroRNAs; Neoplasm Metastasis; Oxidation-Reduction; Oxidative Phosphorylation; Oxygen; Prostatic Neoplasms; Pyruvate Kinase; Thyroid Hormone-Binding Proteins; Thyroid Hormones; Tumor Suppressor Proteins | 2015 |
Sulforaphane-cysteine suppresses invasion via downregulation of galectin-1 in human prostate cancer DU145 and PC3 cells.
Topics: Anticarcinogenic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cysteine; Down-Regulation; Flavonoids; Galectin 1; Gene Expression Regulation, Neoplastic; Humans; Isothiocyanates; Male; MAP Kinase Signaling System; Neoplasm Invasiveness; Phosphorylation; Prostatic Neoplasms; Sulfoxides | 2016 |
Systemic depletion of L-cyst(e)ine with cyst(e)inase increases reactive oxygen species and suppresses tumor growth.
Topics: Animals; Blotting, Western; Breast Neoplasms; Cell Line, Tumor; Cystathionine gamma-Lyase; Cysteine; Cystine; Female; Glutathione; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Macaca fascicularis; Male; Mice; Mice, Knockout; Mice, Transgenic; Neoplasm Transplantation; Oxidative Stress; Polyethylene Glycols; Prostatic Neoplasms; Reactive Oxygen Species; Tumor Suppressor Protein p53 | 2017 |
Mechanical pressure boosting and pressure transfer with low volume displacement.
Topics: Biochemical Phenomena; Cysteine; Cystine; Humans; Male; Methionine; Pressure; Prostatic Neoplasms; Urea | 1947 |
Phenethyl isothiocyanate induces cell cycle arrest and reduction of alpha- and beta-tubulin isotypes in human prostate cancer cells.
Topics: Anticarcinogenic Agents; Antioxidants; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cysteine; Flow Cytometry; G2 Phase; Humans; Isothiocyanates; Leupeptins; Male; Prostatic Neoplasms; Protein Isoforms; Tubulin | 2009 |
Methyl-selenium compounds inhibit prostate carcinogenesis in the transgenic adenocarcinoma of mouse prostate model with survival benefit.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Proliferation; Cysteine; Enzyme-Linked Immunosorbent Assay; In Situ Nick-End Labeling; Insulin-Like Growth Factor I; Male; Mice; Mice, Transgenic; Organoselenium Compounds; Prostatic Neoplasms; Selenocysteine; Selenomethionine | 2009 |
One-carbon metabolism and prostate cancer risk: prospective investigation of seven circulating B vitamins and metabolites.
Topics: Adult; Betaine; Case-Control Studies; Chi-Square Distribution; Choline; Cysteine; Humans; Male; Methionine; Methylmalonic Acid; Middle Aged; One-Carbon Group Transferases; Prospective Studies; Prostatic Neoplasms; Registries; Riboflavin; Statistics, Nonparametric; Sweden; Vitamin B 6 | 2009 |
Antiandrogen withdrawal syndrome and alternative antiandrogen therapy associated with the W741C mutant androgen receptor in a novel prostate cancer xenograft.
Topics: Administration, Oral; Androgen Antagonists; Androgens; Anilides; Animals; Antineoplastic Agents, Hormonal; Cysteine; Drug Administration Schedule; Flutamide; Humans; Male; Mice; Mutation; Neoplasm Transplantation; Nitriles; Prostatic Neoplasms; Receptors, Androgen; Retreatment; Substance Withdrawal Syndrome; Tosyl Compounds; Transplantation, Heterologous; Tryptophan | 2010 |
Selenium, but not lycopene or vitamin E, decreases growth of transplantable dunning R3327-H rat prostate tumors.
Topics: Androgens; Animals; Carotenoids; Cell Proliferation; Cysteine; Lycopene; Male; Neoplasm Transplantation; Organoselenium Compounds; Prostatic Neoplasms; Rats; Selenium; Selenocysteine; Tumor Burden; Vitamin E | 2010 |
Docetaxel-resistant prostate cancer cells remain sensitive to S-trityl-L-cysteine-mediated Eg5 inhibition.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Cysteine; Docetaxel; Drug Screening Assays, Antitumor; Humans; Kinesins; Male; Propidium; Prostatic Neoplasms; Taxoids; Up-Regulation | 2010 |
Proteomic profiling of potential molecular targets of methyl-selenium compounds in the transgenic adenocarcinoma of mouse prostate model.
Topics: Adenocarcinoma; Animals; Biomarkers, Pharmacological; Biomarkers, Tumor; Cysteine; Disease Models, Animal; Male; Metabolome; Mice; Mice, Inbred C57BL; Mice, Transgenic; Models, Biological; Organoselenium Compounds; Prostatic Neoplasms; Proteomics; Selenium Compounds; Selenocysteine; Selenomethionine | 2010 |
Survivin gene silencing sensitizes prostate cancer cells to selenium growth inhibition.
Topics: Animals; Anticarcinogenic Agents; Apoptosis; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Cysteine; Down-Regulation; Drug Synergism; Gene Silencing; Humans; Immunoenzyme Techniques; Inhibitor of Apoptosis Proteins; Male; Mice; Mice, Nude; Neoplasms, Hormone-Dependent; Organoselenium Compounds; Prognosis; Prostatic Neoplasms; Repressor Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Selenocysteine; Survival Rate; Survivin | 2010 |
A potent chemotherapeutic strategy in prostate cancer: S-(methoxytrityl)-L-cysteine, a novel Eg5 inhibitor.
Topics: Animals; Antineoplastic Agents; Biomarkers, Tumor; Cell Line, Tumor; Cell Survival; Cysteine; Docetaxel; Drug Resistance, Neoplasm; Humans; Kinesins; Male; Mice; Mice, Nude; Prostatic Neoplasms; Protein Array Analysis; Taxoids; Trityl Compounds; Xenograft Model Antitumor Assays | 2011 |
A good molecular target for prostate cancer chemotherapy.
Topics: Antineoplastic Agents; Biomarkers, Tumor; Cell Line, Tumor; Cysteine; Drug Resistance, Neoplasm; Humans; Kinesins; Male; Prostatic Neoplasms | 2011 |
Lobe-specific lineages of carcinogenesis in the transgenic adenocarcinoma of mouse prostate and their responses to chemopreventive selenium.
Topics: Adenocarcinoma; Animals; Anticarcinogenic Agents; Cell Lineage; Cysteine; Disease Models, Animal; Immunohistochemistry; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Neoplasm Metastasis; Organoselenium Compounds; Prostatic Neoplasms; Proteomics; Selenocysteine; Seminal Vesicles | 2011 |
Synergistic administration of photothermal therapy and chemotherapy to cancer cells using polypeptide-based degradable plasmonic matrices.
Topics: Benzoquinones; Cell Line, Tumor; Cell Survival; Cysteine; Doxorubicin; Elastin; Gold; HSP90 Heat-Shock Proteins; Humans; Hyperthermia, Induced; Lactams, Macrocyclic; Low-Level Light Therapy; Male; Nanoparticles; Nanotubes; Peptides; Prostatic Neoplasms | 2011 |
Mouse prostate proteomes are differentially altered by supranutritional intake of four selenium compounds.
Topics: Animals; Anticarcinogenic Agents; Cysteine; Gene Expression Profiling; Gene Expression Regulation; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Proteins; Organoselenium Compounds; Prostate; Prostatic Neoplasms; Protein Biosynthesis; Proteomics; RNA, Messenger; Selenium Compounds; Selenocysteine; Selenomethionine; Sodium Selenite; Xenograft Model Antitumor Assays | 2011 |
S-allylcysteine induces cell cycle arrest and apoptosis in androgen-independent human prostate cancer cells.
Topics: Androgens; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Caspase 8; Cell Cycle Checkpoints; Cell Line, Tumor; Cysteine; Garlic; Humans; Male; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2 | 2012 |
Regulation of prostate cancer cell invasion by modulation of extra- and intracellular redox balance.
Topics: Antioxidants; Cell Line, Tumor; Cell Movement; Cell Proliferation; Culture Media, Conditioned; Cysteine; Gelatinases; Gene Knockdown Techniques; Glutathione; Humans; Hydrogen Peroxide; Male; Matrix Metalloproteinase 9; NADPH Oxidase 1; NADPH Oxidases; Neoplasm Invasiveness; Oxidation-Reduction; Prostatic Neoplasms | 2012 |
Fibronectin protects prostate cancer cells from tumor necrosis factor-alpha-induced apoptosis via the AKT/survivin pathway.
Topics: Adenocarcinoma; Adenoviridae; Alanine; Apoptosis; Caspases; Cell Adhesion; Cell Death; Cell Line; Cell Line, Tumor; Cell Survival; Cysteine; DNA Fragmentation; DNA, Complementary; Enzyme Activation; Fibronectins; Genes, Dominant; Humans; Immunoblotting; Immunohistochemistry; Inhibitor of Apoptosis Proteins; Integrin beta1; Male; Microscopy, Fluorescence; Microtubule-Associated Proteins; Models, Biological; Neoplasm Proteins; Oligonucleotides, Antisense; Plasmids; Prostatic Neoplasms; Protein Serine-Threonine Kinases; Protein Structure, Tertiary; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Survivin; Time Factors; Transfection; Tumor Necrosis Factor-alpha; Up-Regulation | 2003 |
Oxidative stress inhibits MEKK1 by site-specific glutathionylation in the ATP-binding domain.
Topics: Adenosine Triphosphate; Alkylation; Amino Acid Sequence; Amino Acid Substitution; Binding Sites; Catalytic Domain; Cell Line, Tumor; Cysteine; Dithiothreitol; Enzyme Inhibitors; Ethylmaleimide; Glutathione; Humans; Lymph Nodes; Male; MAP Kinase Kinase Kinase 1; Molecular Sequence Data; Mutation; Oxidants; Oxidation-Reduction; Oxidative Stress; Peptides; Prostatic Neoplasms; Protein Structure, Tertiary; Valine | 2004 |
Prospects for total synthesis: a vision for a totally synthetic vaccine targeting epithelial tumors.
Topics: Antigens, Tumor-Associated, Carbohydrate; Cancer Vaccines; Carbohydrate Sequence; Cysteine; Hemocyanins; Humans; Lipoproteins; Male; Molecular Sequence Data; Molecular Structure; Neoplasms, Glandular and Epithelial; Prostatic Neoplasms; Vaccines, Conjugate | 2004 |
Human Kruppel-like factor 5 is a target of the E3 ubiquitin ligase WWP1 for proteolysis in epithelial cells.
Topics: Amino Acid Motifs; Blotting, Western; Breast Neoplasms; Catalysis; Cell Line, Tumor; Cysteine; DNA; Epithelial Cells; Female; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Glutathione Transferase; Humans; Immunoprecipitation; Kruppel-Like Transcription Factors; Luciferases; Male; Microscopy, Confocal; Microscopy, Fluorescence; Neoplasms; Plasmids; Prostatic Neoplasms; Proteasome Endopeptidase Complex; Protein Binding; Protein Biosynthesis; Protein Structure, Tertiary; Recombinant Fusion Proteins; Reverse Transcriptase Polymerase Chain Reaction; RNA; RNA, Small Interfering; Time Factors; Transcriptional Activation; Transfection; Ubiquitin; Ubiquitin-Protein Ligases | 2005 |
N-methyl-D-aspartate receptor in human prostate cancer.
Topics: Breast; Cell Line; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Cysteine; Dizocilpine Maleate; Humans; Immunohistochemistry; Male; Memantine; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Receptors, N-Methyl-D-Aspartate | 2005 |
Monomethylated selenium inhibits growth of LNCaP human prostate cancer xenograft accompanied by a decrease in the expression of androgen receptor and prostate-specific antigen (PSA).
Topics: Animals; Anticarcinogenic Agents; Cell Line, Tumor; Cell Proliferation; Cysteine; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Mice, Nude; Organoselenium Compounds; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; Selenium; Selenocysteine; Xenograft Model Antitumor Assays | 2006 |
The mechanism of methylselenocysteine and docetaxel synergistic activity in prostate cancer cells.
Topics: Animals; Anticarcinogenic Agents; Antineoplastic Agents; Apoptosis; Caspase 3; Cell Line, Tumor; Cysteine; Docetaxel; Down-Regulation; Drug Synergism; Enzyme Activation; Inhibitor of Apoptosis Proteins; Male; Mice; Microtubule-Associated Proteins; Neoplasm Proteins; Organoselenium Compounds; Prostatic Neoplasms; Selenocysteine; Survivin; Taxoids | 2006 |
S-allylcysteine, a water-soluble garlic derivative, suppresses the growth of a human androgen-independent prostate cancer xenograft, CWR22R, under in vivo conditions.
Topics: Androgens; Animals; Antineoplastic Agents; Cysteine; Drug Screening Assays, Antitumor; Male; Mice; Mice, Nude; Neoplasms, Hormone-Dependent; Prostate-Specific Antigen; Prostatic Neoplasms; Transplantation, Heterologous; Treatment Outcome | 2007 |
Garlic-derived S-allylmercaptocysteine is a novel in vivo antimetastatic agent for androgen-independent prostate cancer.
Topics: Androgens; Animals; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Cysteine; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Resistance, Neoplasm; Garlic; Green Fluorescent Proteins; Humans; Male; Mice; Mice, SCID; Neoplasm Metastasis; Prostatic Neoplasms; Transfection; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2007 |
Evidence of a novel docetaxel sensitizer, garlic-derived S-allylmercaptocysteine, as a treatment option for hormone refractory prostate cancer.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Cadherins; Cell Division; Cell Line, Tumor; Cysteine; Docetaxel; Down-Regulation; Drug Synergism; Flow Cytometry; G2 Phase; Garlic; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Male; Mice; Mice, Nude; Neoplasms, Experimental; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Taxoids; Transplantation, Heterologous; Tumor Stem Cell Assay; Up-Regulation | 2008 |
Radiolabeled bombesin analogs for prostate cancer diagnosis: preclinical studies.
Topics: Animals; Bombesin; Cell Line, Tumor; Cysteine; Disease Models, Animal; Drug Design; Drug Evaluation, Preclinical; Drug Stability; Hydrazines; Hydrophobic and Hydrophilic Interactions; Isotope Labeling; Male; Metabolic Clearance Rate; Mice; Niacinamide; Nitrogen Compounds; Organotechnetium Compounds; Pancreas; Phosphines; Prostate; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Bombesin; Tissue Distribution | 2008 |
N-[N-[(S)-1,3-Dicarboxypropyl]carbamoyl]-4-[18F]fluorobenzyl-L-cysteine, [18F]DCFBC: a new imaging probe for prostate cancer.
Topics: Animals; Cysteine; Fluorine Radioisotopes; Humans; Male; Mice; Positron-Emission Tomography; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals | 2008 |
A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases.
Topics: 3T3 Cells; Amino Acid Sequence; Animals; Base Sequence; Blotting, Northern; Capillaries; Cattle; Cell Line; Chironomidae; Cloning, Molecular; Consensus Sequence; Cysteine; DNA Primers; Endothelial Growth Factors; Endothelium, Vascular; Enzyme Activation; Gene Expression; Growth Substances; Humans; Male; Mice; Molecular Sequence Data; Platelet-Derived Growth Factor; Prostatic Neoplasms; Receptor Protein-Tyrosine Kinases; Receptors, Cell Surface; Receptors, Growth Factor; Receptors, Vascular Endothelial Growth Factor; Recombinant Proteins; Salivary Glands; Sequence Homology, Amino Acid; Spodoptera; Transfection; Tumor Cells, Cultured; Vascular Endothelial Growth Factor C; Vascular Endothelial Growth Factor Receptor-3 | 1996 |
S-allylmercaptocysteine inhibits cell proliferation and reduces the viability of erythroleukemia, breast, and prostate cancer cell lines.
Topics: Antineoplastic Agents; Breast Neoplasms; Cell Division; Cell Survival; Cysteine; Humans; Leukemia, Erythroblastic, Acute; Male; Prostatic Neoplasms; Tumor Cells, Cultured | 1997 |
Effects of garlic thioallyl derivatives on growth, glutathione concentration, and polyamine formation of human prostate carcinoma cells in culture.
Topics: Antineoplastic Agents, Phytogenic; Cell Division; Cysteine; Garlic; Glutathione; Humans; Male; Plant Extracts; Plants, Medicinal; Polyamines; Prostatic Neoplasms; Tumor Cells, Cultured | 1997 |
Specific transcription factors prognostic for prostate cancer progression.
Topics: Binding Sites; Cysteine; Disease Progression; DNA Probes; DNA-Binding Proteins; DNA, Neoplasm; Humans; Male; Neoplasm Staging; Prognosis; Prostatic Neoplasms; Proto-Oncogene Proteins c-fos; Proto-Oncogene Proteins c-jun; Sensitivity and Specificity; STAT1 Transcription Factor; Trans-Activators; Transcription Factors; Tumor Cells, Cultured | 1998 |
Gamma-glutamyl transpeptidase accelerates tumor growth and increases the resistance of tumors to cisplatin in vivo.
Topics: Animals; Antineoplastic Agents; Cisplatin; Culture Media; Cysteine; Drug Resistance, Neoplasm; gamma-Glutamyltransferase; Glutathione; Humans; Kidney Tubular Necrosis, Acute; Kidney Tubules, Proximal; Male; Mice; Mice, Nude; Prostatic Neoplasms; Recombinant Fusion Proteins; Transfection; Tumor Cells, Cultured | 1999 |
A C619Y mutation in the human androgen receptor causes inactivation and mislocalization of the receptor with concomitant sequestration of SRC-1 (steroid receptor coactivator 1)
Topics: Cell Nucleus; Chromosome Mapping; Cysteine; Cytoplasm; DNA; HeLa Cells; Histone Acetyltransferases; Humans; Male; Middle Aged; Mutation; Nuclear Receptor Coactivator 1; Prostatic Neoplasms; Receptors, Androgen; Response Elements; Transcription Factors; Transfection; Tyrosine; X Chromosome | 1999 |
Alterations of prostate biomarker expression and testosterone utilization in human LNCaP prostatic carcinoma cells by garlic-derived S-allylmercaptocysteine.
Topics: Adenocarcinoma; Antigens, Neoplasm; Antigens, Surface; Biomarkers, Tumor; Carboxypeptidases; Cell Division; Culture Media; Cysteine; Drug Interactions; gamma-Glutamyl Hydrolase; Garlic; Glutamate Carboxypeptidase II; Growth Inhibitors; Humans; Male; Plants, Medicinal; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; Secretory Rate; Testosterone; Tumor Cells, Cultured | 2000 |
Nonredundant antioxidant defense by multiple two-cysteine peroxiredoxins in human prostate cancer cells.
Topics: Animals; Antibody Specificity; Antineoplastic Agents; Antioxidants; Cysteine; Doxorubicin; Etoposide; Humans; Hydrogen Peroxide; Immune Sera; Male; Mice; Oxidative Stress; Paclitaxel; Peroxidases; Peroxiredoxin III; Peroxiredoxins; Prostatic Neoplasms; Protein Isoforms; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2002 |
Collagenase activity in cultures of rat prostate carcinoma.
Topics: Animals; Blood; Cysteine; Edetic Acid; Hydrogen-Ion Concentration; Male; Microbial Collagenase; Molecular Weight; Prostatic Neoplasms; Protease Inhibitors; Rats | 1979 |